MetLife Inc (MET)
Official siteFINANCIAL SERVICES • INSURANCE - LIFE • NYSE
Market Cap: $64.51B
Last updated: Nov 17, 2026 at 4:30 PM ET
MetLife Inc (MET) Stock Chart
MetLife (MET) has a latest price of $101.53 on Nov 17, 2026, 4.9% below its 52-week high of $106.72. Its price rose 30.1% over the past 12 months. The month-end price rose 113.0% over the 10 years through Oct 2026, a compound annual rate of 7.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $100.02 in Oct 2026 and its lowest $30.57 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MET with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MET.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 7.4%, and over 6 months it rose 26.0%. The month-end price rose 66.7% over the 3 years through Oct 2026, a compound annual rate of 18.6%.
| Period | Change |
|---|---|
| 1 month | +2.6% |
| 3 months | +7.4% |
| 6 months | +26.0% |
| 12 months | +30.1% |
| 12 months, with dividends | +33.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +66.7% | +18.6% |
| 5 years | +59.3% | +9.8% |
| 10 years | +113.0% | +7.9% |
Price by Year
Its best calendar year was 2021, when the price rose 33.1%, and its weakest was 2018, when it fell 18.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $100.02 | +26.7% |
| 2025 | $78.94 | -3.6% |
| 2024 | $81.88 | +23.8% |
| 2023 | $66.13 | -8.6% |
| 2022 | $72.37 | +15.8% |
| 2021 | $62.49 | +33.1% |
| 2020 | $46.95 | -7.9% |
| 2019 | $50.97 | +24.1% |
| 2018 | $41.06 | -18.8% |
| 2017 | $50.56 | -6.2% |
Trading Range
The price is 3.1% above its 50-day average of $98.49 and 17.5% above its 200-day average of $86.43.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $101.53 | |
| 52-week high | $106.72 | -4.9% |
| 52-week low | $66.02 | +53.8% |
| 50-day average | $98.49 | +3.1% |
| 200-day average | $86.43 | +17.5% |
Price Risk
Over 3 years, its largest fall from a peak was 22.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.63 |
| Largest fall, 1 year | -18.6% |
| Largest fall, 3 years | -22.1% |
Valuation
MetLife traded at 9.0x earnings at the end of 2025, against a 5-year median of 9.4x and a 10-year median of 9.1x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MET
What is MET's 1-year price change?
MetLife's price rose 30.1% over the past 12 months. With dividends included, the 12-month total return was 33.1%.
What is MET's 5-year price change?
MetLife's month-end price rose 59.3% over the 5 years through Oct 2026, a compound annual rate of 9.8%. These figures leave out dividends.
What is MET's 52-week high and low?
MetLife's 52-week high is $106.72 and its 52-week low is $66.02. Its latest price of $101.53 on Nov 17, 2026 is 4.9% below the high.
What is MET's beta?
MetLife's 1-year beta against the S&P 500 is 0.63, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 18.6%.
Is the MET chart free?
Yes. Advanced Charting for MET is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MET pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts